NIH PAR · NCATS · R03
PAR-25-155: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The purpose of this NOFO is to enhance the capability of NCATS CTSA Program KL2 scholars and recipients of diversity and re-entry supplements supported by the CTSA Program to conduct research as they complete the transition to fully independent academic translational scientists. These R03 grants will support different clinical and translational science research projects, including pilot and feasibility studies; secondary data analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Research proposed in the R03 application may or may not include patient-oriented research. The R03 is, therefore,…
- NOFO number
- PAR-25-155
- Type
- PAR
- Activity code
- R03
- Primary institute
- NCATS · National Center for Advancing Translational Sciences
- Clinical trials
- Optional
- Posted
- Dec 11, 2024
- Opens
- Jan 17, 2025
- Expires
- Oct 20, 2026
PAR-25-155 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 17, 2025 | February 17, 2025 | Not Applicable | June 2025 | October 2025 | October 2025 |
| June 17, 2025 | June 17, 2025 | Not Applicable | October 2025 | January 2026 | April 2026 |
| October 17, 2025 | October 17, 2025 | Not Applicable | February 2026 | May 2026 | July 2026 |
| February 18, 2026 | February 18, 2026 | Not Applicable | June 2026 | October 2026 | October 2026 |
| June 17, 2026 | June 17, 2026 | Not Applicable | October 2026 | January 2027 | April 2027 |
| October 19, 2026 | October 19, 2026 | Not Applicable | February 2027 | May 2027 | July 2027 |
Projects funded under PAR-25-155
NIH RePORTER lists 5 projects funded under PAR-25-155 in FY2022–FY2026, with $814K in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
5
Distinct projects, FY2022–FY2026
New awards
5
Type 1 (new project) award records
NIH funding
$814K
Award dollars under PAR-25-155, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 5 | 5 | $814K |
Institutions with the most funding
- Hospital for Special Surgery$179K · 1 project
- Icahn School of Medicine at Mount Sinai$168K · 1 project
- Pennsylvania State University, the$157K · 1 project
- Washington University$156K · 1 project
- Loyola University Chicago$154K · 1 project
Funding institutes
- NCATS$814K · 5
Activity codes funded
- R035 records
Most recent new awards
- Subjective Cognitive Dysfunction in Adults with Systemic Lupus Erythematosus Across the Lifespan (opens NIH RePORTER)
Hospital for Special Surgery · 1R03TR005820-01A1 · NCATS · Notice Sep 14, 2026
$179KR03
- Advancing Scalable AI-Powered Clinical Decision Support for AUC-Guided Vancomycin Dosing in ICU Patients (opens NIH RePORTER)
Loyola University Chicago · 1R03TR006291-01 · NCATS · Notice Sep 14, 2026
$154KR03
- Establishing a National Consortium to Investigate Adaptive Immune Responses in Invasive Fungal Sinusitis (opens NIH RePORTER)
Washington University · 1R03TR006415-01 · NCATS · Notice Jul 20, 2026
$156KR03
- Bridging the Gap: Advancing Rural Health Research with the Wear-IT Research Platform and Edge-of-Cloud Computing (opens NIH RePORTER)
Pennsylvania State University, the · 1R03TR005950-01 · NCATS · Notice Jun 3, 2026
$157KR03
- Leveraging a lung organoid model to study early cystic fibrosis lung disease (opens NIH RePORTER)
Icahn School of Medicine at Mount Sinai · 1R03TR005349-01A1 · NCATS · Notice May 5, 2026
$168KR03
What its predecessor PAR-24-042 funded
PAR-25-155 reissues PAR-24-042. Its funding history is the best guide to who wins under this program: 5 projects and $781K in FY2022–FY2026.
Projects funded
5
Distinct projects, FY2022–FY2026
New awards
5
Type 1 (new project) award records
NIH funding
$781K
Award dollars under PAR-24-042, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 5 | 5 | $781K |
| FY2026 | 0 | 0 | $0 |
Institutions with the most funding
- University of Tx MD Anderson Can Ctr$163K · 1 project
- Cincinnati Childrens Hosp Med Ctr$162K · 1 project
- University of Texas Hlth Sci Ctr Houston$156K · 1 project
- University of Minnesota$155K · 1 project
- Stanford University$144K · 1 project
Funding institutes
- NCATS$781K · 5
Activity codes funded
- R035 records
Most recent new awards
- Evaluating a multimodality platform of tissue, blood and advanced imaging-based biomarkers to predict response to neoadjuvant immunotherapy and radiotherapy in melanoma (opens NIH RePORTER)
University of Tx MD Anderson Can Ctr · 1R03TR005344-01 · NCATS · Notice Sep 11, 2025
$163KR03
- Analysis of clinical trial data to better understand Long Covid (opens NIH RePORTER)
University of Minnesota · 1R03TR004982-01A1 · NCATS · Notice Sep 2, 2025
$155KR03
- A Novel Ultrasound Score to Improve the Assessment of Joint Inflammation in Children with Chronic Musculoskeletal Pain (opens NIH RePORTER)
Cincinnati Childrens Hosp Med Ctr · 1R03TR004974-01A1 · NCATS · Notice Aug 27, 2025
$162KR03
- Effects of Earlier And Higher Vitamin D Supplementation in Extremely Preterm Newborns at 2 Years Of Age (opens NIH RePORTER)
University of Texas Hlth Sci Ctr Houston · 1R03TR005545-01 · NCATS · Notice Aug 22, 2025
$156KR03
- Advancing catheter electrochemical impedance spectroscopy for precision medicine of embolotherapy (opens NIH RePORTER)
Stanford University · 1R03TR005547-01 · NCATS · Notice Aug 20, 2025
$144KR03
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-155. Contact the program officer at the institute that fits your research before applying.
- NCATS · National Center for Advancing Translational Sciences
- none
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewResubmission - Resubmission of Applications submitted to PAR-24-042 and this NOFO The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to direct costs up to 50,000 per year and need to reflect the actual needs of the proposed project.
- Project period
- The scope of the proposed project should determine the project period. The maximum period of support is 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-042.
Other open NOFOs for R03
- PAR-25-122Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)NCATS · next due Oct 16, 2026
- PA-25-302NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)NIH · next due Oct 16, 2026
- PAS-27-028Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)NIDA · next due Oct 16, 2026
- PAR-27-074Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed)NIAMS · next due Oct 16, 2026
- PAR-25-370Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)NHGRI · next due Oct 16, 2026
- PAR-25-091Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)NIDDK · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.